Top compounds associated with response to CLINT1


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.02
mRNA AZD7762 GDSC1000 pan-cancer AAC 0.077 0.02
mRNA Cytarabine GDSC1000 pan-cancer AAC 0.084 0.02
mRNA NSC-207895 GDSC1000 pan-cancer AAC -0.078 0.02
mRNA PI-103 GDSC1000 pan-cancer AAC -0.071 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.075 0.02
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.085 0.02
mRNA GW-2580 GDSC1000 pan-cancer AAC -0.079 0.02
Download CSV